1.190USD+10.19%Mkt Cap: 9.60M $P/E: —2d ago
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research a…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap9.60M $
Enterprise Value-155.13K $
Revenue (TTM)7.48M $
Gross Profit4.77M $
Net Income (TTM)-5.22M $
Revenue/Share1.160 USD
Last Price1.190 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-118.00
PEG—
EV/EBITDA0.03
EV/Revenue-0.02
P/S1.27
P/B1.04
EPS (TTM)-0.53
EPS (Forward)-0.01
52W Range
1.08080% of range1.217
52W High1.217 USD
52W Low1.080 USD
Profitability
Gross Margin65.39%
Oper. Margin-47.16%
EBITDA Margin-63.39%
Profit Margin-71.58%
ROE-64.64%
ROA-51.49%
Growth
Revenue Growth4.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.70M $
CapEx (TTM)—
FCF Margin-45.75%
FCF Yield-35.62%
Net Debt-9.79M $
Net Debt/EBITDA2.07
Balance Sheet
Debt/Equity0.01
Current Ratio8.04
Quick Ratio6.75
Book Value/Sh1.133 USD
Cash/Share1.224 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.990 USD
Upside (mean)+235.3%
Target Range3.990 USD – 3.990 USD
# Analysts1
Ownership
Shares Out.8.07M
Float7.99M
Insiders0.00%
Institutions0.97%
Short Interest
Short Ratio0.8d
Short % Float0.71%
Short % Out.0.45%
Shares Short36.21K
Short (prev mo.)73.74K
Technical
SMA 501.136 (+4.8%)
SMA 2001.049 (+13.4%)
Beta0.51
S&P 52W Chg18.16%
Avg Vol (30d)30.91K
Avg Vol (10d)20.28K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—